Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational study.
Descamps A, Lenzi N, Galtier F, Lainé F, Lesieur Z, Vanhems P, Amour S, L'Honneur AS, Fidouh N, Foulongne V, Lagathu G, Duval X, Merle C, Lina B, Carrat F, Launay O, Loubet P; FLUVAC study group. Descamps A, et al. Among authors: galtier f. Eur Respir J. 2022 Mar 3;59(3):2100651. doi: 10.1183/13993003.00651-2021. Print 2022 Mar. Eur Respir J. 2022. PMID: 34446468 Free article.
Questions for biotechs: REIVAC.
Loulergue P, Duval X, Galtier F, Lenzi N, Laurichesse H, Launay O. Loulergue P, et al. Among authors: galtier f. Hum Vaccin. 2011 Feb;7(2):142-3. doi: 10.4161/hv.7.2.15130. Hum Vaccin. 2011. PMID: 21937881 No abstract available.
Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults: new considerations for the management of patients with tetanus-prone injuries.
Laurichesse H, Zimmermann U, Galtier F, Launay O, Duval X, Richard P, Sadorge C, Soubeyrand B. Laurichesse H, et al. Among authors: galtier f. Hum Vaccin Immunother. 2012 Dec 1;8(12):1875-81. doi: 10.4161/hv.22083. Epub 2012 Oct 2. Hum Vaccin Immunother. 2012. PMID: 23032160 Free PMC article. Clinical Trial.
Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine.
Launay O, Paul S, Servettaz A, Roguet G, Rozenberg F, Lucht F, Lambert C, Presles E, Goulvestre C, Méritet JF, Galtier F, Dubray C, Lebon P, Weill B, Batteux F. Launay O, et al. Among authors: galtier f. Vaccine. 2013 Aug 2;31(35):3492-501. doi: 10.1016/j.vaccine.2013.05.095. Epub 2013 Jun 11. Vaccine. 2013. PMID: 23764537 Free article. Clinical Trial.
Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness.
Falsey AR, McElhaney JE, Beran J, van Essen GA, Duval X, Esen M, Galtier F, Gervais P, Hwang SJ, Kremsner P, Launay O, Leroux-Roels G, McNeil SA, Nowakowski A, Richardus JH, Ruiz-Palacios G, St Rose S, Devaster JM, Oostvogels L, Durviaux S, Taylor S. Falsey AR, et al. Among authors: galtier f. J Infect Dis. 2014 Jun 15;209(12):1873-81. doi: 10.1093/infdis/jit839. Epub 2014 Jan 29. J Infect Dis. 2014. PMID: 24482398 Free PMC article.
Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study.
Launay O, Abitbol V, Krivine A, Slama LB, Bourreille A, Dupas JL, Hébuterne X, Savoye G, Deplanque D, Bouhnik Y, Pelletier AL, Galtier F, Laharie D, Nachury M, Zerbib F, Allez M, Bommelaer G, Duclos B, Lucht F, Gougeon ML, Tartour E, Rozenberg F, Hanslik T, Beaugerie L, Carrat F; MICIVAX Study Group. Launay O, et al. Among authors: galtier f. J Crohns Colitis. 2015 Dec;9(12):1096-107. doi: 10.1093/ecco-jcc/jjv152. Epub 2015 Sep 7. J Crohns Colitis. 2015. PMID: 26351392 Clinical Trial.
Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study.
Loubet P, Samih-Lenzi N, Galtier F, Vanhems P, Loulergue P, Duval X, Jouneau S, Postil D, Rogez S, Valette M, Merle C, Régis C, Costa Y, Lesieur Z, Tattevin P, Lina B, Carrat F, Launay O; FLUVAC Study Group. Loubet P, et al. Among authors: galtier f. J Clin Virol. 2016 Jun;79:68-73. doi: 10.1016/j.jcv.2016.04.005. Epub 2016 Apr 12. J Clin Virol. 2016. PMID: 27105315 Free article.
Seasonal influenza vaccination of high-risk adults.
Loubet P, Loulergue P, Galtier F, Launay O. Loubet P, et al. Among authors: galtier f. Expert Rev Vaccines. 2016 Dec;15(12):1507-1518. doi: 10.1080/14760584.2016.1188696. Epub 2016 May 27. Expert Rev Vaccines. 2016. PMID: 27169689 Review.
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis.
Ruiz-Palacios GM, Leroux-Roels G, Beran J, Devaster JM, Esen M, Launay O, McElhaney JE, van Essen GA, Benoit A, Claeys C, Dewé W, Durand C, Duval X, Falsey AR, Feldman G, Galtier F, Gervais P, Hwang SJ, McNeil S, Richardus JH, Trofa A, Oostvogels L; Influence65 study group. Ruiz-Palacios GM, et al. Among authors: galtier f. Hum Vaccin Immunother. 2016 Dec;12(12):3043-3055. doi: 10.1080/21645515.2016.1219809. Hum Vaccin Immunother. 2016. PMID: 27690762 Free PMC article. Clinical Trial.
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
Rondy M, Larrauri A, Casado I, Alfonsi V, Pitigoi D, Launay O, Syrjänen RK, Gefenaite G, Machado A, Vučina VV, Horváth JK, Paradowska-Stankiewicz I, Marbus SD, Gherasim A, Díaz-González JA, Rizzo C, Ivanciuc AE, Galtier F, Ikonen N, Mickiene A, Gomez V, Kurečić Filipović S, Ferenczi A, Korcinska MR, van Gageldonk-Lafeber R; I-MOVE+ hospital working group; Valenciano M. Rondy M, et al. Among authors: galtier f. Euro Surveill. 2017 Jul 27;22(30):30580. doi: 10.2807/1560-7917.ES.2017.22.30.30580. Euro Surveill. 2017. PMID: 28797322 Free PMC article.
116 results